SAGA Diagnostics
SAGA Diagnostics AB is a personalized cancer diagnostics and disease monitoring company focused on molecular genetic analyses of a powerful cancer biomarker: circulating tumor DNA (ctDNA). The company was founded in 2016 as a spin-out from a highly successful research group at Lund University, with a mission to improve precision cancer medicine, provide more accurate treatment monitoring, and improve patient survival using minimally-invasive liquid biopsy cancer testing services and kits. The SAGA team consists of renowned scientists, highly qualified staff and an experienced management team who work together to launch SAGA’s ultrasensitive services and products as part of the ongoing revolution in cancer research, drug development, and clinical diagnostics. SAGA’s proprietary tests can help patients, oncologists, and drug developers detect actionable mutations, stratify patient groups, and monitor treatment response, residual disease, and disease recurrence at an unprecedented sensitivity.
Domain
sagadiagnostics.com
Country
SwedenIndustry
BiotechnologyEmployees
11-50
Last Funding
$12.4M
Founded
2015
Tech Stack (17 technologies)
Frequently Asked Questions
What technologies does SAGA Diagnostics use?+
SAGA Diagnostics uses 17 technologies including Elementor, Google Analytics, Google Tag Manager.
What industry is SAGA Diagnostics in?+
SAGA Diagnostics operates in the Biotechnology industry.
Where is SAGA Diagnostics based?+
SAGA Diagnostics is headquartered in Sweden.
Explore More
Need this data at scale?
Get ready-to-use datasets: companies, technologies, and tech adoption signals across 3M+ websites.
Browse DatasetsData last updated: June 2026